Arjun A Raghavan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Arjun A Raghavan

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

The Canadian Journal of Cardiology|October 13, 2025

Heart in the Crossfire: Immune Checkpoint Inhibitor-Mediated CardiotoxicityVineet Goyal, Arjun A Raghavan, Davinder S Jassal

Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 8, 2023

Effectiveness and Safety of Immune Checkpoint Inhibitors in Cancer Patients With Autoimmune Disease: A Retrospective Cohort StudyArjun A Raghavan, Sid Goutam, Grace Musto, et al.

Lung Cancer (Amsterdam, Netherlands)|March 1, 2026

Outcomes and toxicities of immune checkpoint inhibitors in patients with lung cancer and pre-existing autoimmune diseaseSiddhartha Goutam, Arjun A Raghavan, Hans Alday, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

The Canadian Journal of Cardiology|October 13, 2025

Heart in the Crossfire: Immune Checkpoint Inhibitor-Mediated CardiotoxicityVineet Goyal, Arjun A Raghavan, Davinder S Jassal

Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 8, 2023

Effectiveness and Safety of Immune Checkpoint Inhibitors in Cancer Patients With Autoimmune Disease: A Retrospective Cohort StudyArjun A Raghavan, Sid Goutam, Grace Musto, et al.

Lung Cancer (Amsterdam, Netherlands)|March 1, 2026

Outcomes and toxicities of immune checkpoint inhibitors in patients with lung cancer and pre-existing autoimmune diseaseSiddhartha Goutam, Arjun A Raghavan, Hans Alday, et al.

Pageof 1